Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Description The Molecular Nanophotonics Group at the Faculty of Physics and Earth System Sciences at Leipzig University is currently offering a doctoral researcher position under the supervision
-
Support Grant of up to £5,000 Access to Disabled Student Allowance, paid sick leave and paid parental leave Supervisor: University of Warwick: Dr Arnab Palit, Prof Andy Metcalfe Eligibility: Satisfy UKRI's
-
internships at KU Leuven (Prof. Rodolphe Sepulchre) and at TU Delft (Prof. Charlotte Frenkel) Participate in yearly retreats organized by the doctoral network participants Support the dissemination of software
-
by Prof Anu Realo and Prof Kai Pata and is funded by the European Commission’s Horizon Europe “Widening Participation and Spreading Excellence” program. Running from 2025 to 2029, SustainERA will
-
the fellow Prof J. L. Bamber, University of Bristol (https://research-information.bris.ac.uk/en/persons/jonathan-l-bamber), Prof X. Zhu (https://www.asg.ed.tum.de/en/sipeo/home/) and Dr M. Passaro in
-
22 Aug 2025 Job Information Organisation/Company Technische Universitaet Darmstadt Department Chemistry Research Field Chemistry » Physical chemistry Researcher Profile First Stage Researcher (R1
-
a highly motivated candidate with: A first-class or upper second-class degree (or equivalent) in Materials Science, Chemistry, Physics, Chemical Engineering, or a related discipline. Experience in
-
Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg | Magdeburg, Sachsen Anhalt | Germany | 8 days ago
The Department of Process Systems Engineering (Director: Prof. Dr.-Ing. Kai Sundmacher) at the Max Planck Institute for Dynamics of Complex Technical Systems is inviting applications for the PhD
-
Supervisory Team: Prof Middleton, Prof Gandhi PhD Supervisor: Matt Middleton Project description: We know of only 20 or so black holes in our galaxy yet predict there should be 10s of millions
-
The vacancy is within the group of Associate Prof. Dr. Anna Salvati at the Department of Nanomedicine Drug Targeting of the Groningen Research Institute of Pharmacy (GRIP), Faculty of Science and